FI64938C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat - Google Patents
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat Download PDFInfo
- Publication number
- FI64938C FI64938C FI781867A FI781867A FI64938C FI 64938 C FI64938 C FI 64938C FI 781867 A FI781867 A FI 781867A FI 781867 A FI781867 A FI 781867A FI 64938 C FI64938 C FI 64938C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- therapeutic
- procedure
- derivatives
- reacted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH752077 | 1977-06-20 | ||
CH752077 | 1977-06-20 | ||
CH286578 | 1978-03-16 | ||
CH286578 | 1978-03-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI781867A FI781867A (fi) | 1978-12-21 |
FI64938B FI64938B (fi) | 1983-10-31 |
FI64938C true FI64938C (fi) | 1984-02-10 |
Family
ID=25691589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI781867A FI64938C (fi) | 1977-06-20 | 1978-06-12 | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0000150B1 (ja) |
JP (1) | JPS54103876A (ja) |
AT (1) | AT376220B (ja) |
AU (1) | AU524000B2 (ja) |
CA (1) | CA1105463A (ja) |
CY (1) | CY1239A (ja) |
DE (1) | DE2860708D1 (ja) |
DK (1) | DK149855C (ja) |
ES (1) | ES470917A1 (ja) |
FI (1) | FI64938C (ja) |
HK (1) | HK65184A (ja) |
IE (1) | IE47212B1 (ja) |
IL (1) | IL54948A (ja) |
IT (1) | IT1105364B (ja) |
LU (1) | LU88342I2 (ja) |
MY (1) | MY8500041A (ja) |
NL (1) | NL930126I2 (ja) |
NZ (1) | NZ187617A (ja) |
PT (1) | PT68191A (ja) |
SG (1) | SG20584G (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH639659A5 (de) * | 1978-12-18 | 1983-11-30 | Sandoz Ag | Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung. |
DK525179A (da) * | 1978-12-18 | 1980-06-19 | Sandoz Ag | Fremgangsmaade til fremstilling af benzoxadiazoler og benzothiazoler |
BE886259A (fr) * | 1979-11-23 | 1981-05-20 | Sandoz Sa | Nouveaux medicament a base de derives de la 1,4-dihydropyridine, pour le traitement de l'insuffisance cerebrovasculaire ou a action spamolytique |
CH655658B (ja) * | 1980-09-18 | 1986-05-15 | ||
FI813460L (fi) * | 1980-11-10 | 1982-05-11 | Sandoz Ag | Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner |
DE3269219D1 (en) * | 1981-11-17 | 1986-03-27 | Fisons Plc | Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals |
DE3207982A1 (de) * | 1982-03-05 | 1983-09-08 | Bayer Ag, 5090 Leverkusen | Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln |
DE3208628A1 (de) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
ZA83959B (en) * | 1982-03-10 | 1984-09-26 | Sandoz Ltd | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
FR2528431B1 (fr) * | 1982-06-15 | 1986-01-10 | Sandoz Sa | Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments |
FR2554109A1 (fr) * | 1983-11-01 | 1985-05-03 | Sandoz Sa | Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments |
IE57810B1 (en) * | 1984-03-27 | 1993-04-21 | Delagrange Lab | 1,4-dihydropyridine derivatives,their preparation and their use |
HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
GB8428552D0 (en) * | 1984-11-12 | 1984-12-19 | Sandoz Ltd | Organic compounds |
US5260321A (en) * | 1984-11-12 | 1993-11-09 | Sandoz Ltd. | Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins |
GB8616047D0 (en) * | 1986-07-01 | 1986-08-06 | Sandoz Ltd | A 1 4-dihydropyridine derivatives |
EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
-
1978
- 1978-06-12 FI FI781867A patent/FI64938C/fi not_active IP Right Cessation
- 1978-06-12 DK DK262578A patent/DK149855C/da not_active IP Right Cessation
- 1978-06-15 DE DE7878100165T patent/DE2860708D1/de not_active Expired
- 1978-06-15 CY CY1239A patent/CY1239A/xx unknown
- 1978-06-15 EP EP78100165A patent/EP0000150B1/en not_active Expired
- 1978-06-19 CA CA305,727A patent/CA1105463A/en not_active Expired
- 1978-06-19 PT PT68191A patent/PT68191A/pt unknown
- 1978-06-19 IT IT49939/78A patent/IT1105364B/it active Protection Beyond IP Right Term
- 1978-06-19 NZ NZ187617A patent/NZ187617A/xx unknown
- 1978-06-19 AT AT0443178A patent/AT376220B/de not_active IP Right Cessation
- 1978-06-19 ES ES470917A patent/ES470917A1/es not_active Expired
- 1978-06-19 AU AU37252/78A patent/AU524000B2/en not_active Expired
- 1978-06-19 IE IE1231/78A patent/IE47212B1/en not_active IP Right Cessation
- 1978-06-19 JP JP7332778A patent/JPS54103876A/ja active Granted
- 1978-06-19 IL IL54948A patent/IL54948A/xx unknown
-
1984
- 1984-03-05 SG SG205/84A patent/SG20584G/en unknown
- 1984-08-23 HK HK651/84A patent/HK65184A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY41/85A patent/MY8500041A/xx unknown
-
1993
- 1993-06-30 LU LU88342C patent/LU88342I2/fr unknown
- 1993-07-01 NL NL930126C patent/NL930126I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
MY8500041A (en) | 1985-12-31 |
DE2860708D1 (en) | 1981-08-27 |
FI64938B (fi) | 1983-10-31 |
DK262578A (da) | 1978-12-21 |
PT68191A (fr) | 1978-07-01 |
CA1105463A (en) | 1981-07-21 |
HK65184A (en) | 1984-08-31 |
EP0000150B1 (en) | 1981-05-20 |
DK149855B (da) | 1986-10-13 |
NL930126I2 (nl) | 1995-02-16 |
JPS6360755B2 (ja) | 1988-11-25 |
IE781231L (en) | 1978-12-20 |
AT376220B (de) | 1984-10-25 |
NZ187617A (en) | 1980-12-19 |
CY1239A (en) | 1984-06-29 |
ES470917A1 (es) | 1979-10-01 |
FI781867A (fi) | 1978-12-21 |
AU3725278A (en) | 1980-01-03 |
EP0000150A1 (en) | 1979-01-10 |
NL930126I1 (nl) | 1993-11-01 |
JPS54103876A (en) | 1979-08-15 |
DK149855C (da) | 1987-04-21 |
ATA443178A (de) | 1984-03-15 |
SG20584G (en) | 1985-03-08 |
AU524000B2 (en) | 1982-08-26 |
IL54948A0 (en) | 1978-08-31 |
LU88342I2 (fr) | 1994-05-04 |
IT1105364B (it) | 1985-10-28 |
IE47212B1 (en) | 1984-01-25 |
IL54948A (en) | 1982-01-31 |
IT7849939A0 (it) | 1978-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI64938C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat | |
US4466972A (en) | Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them | |
US4921863A (en) | Cyclic amine derivatives | |
NL193066C (nl) | Methyl,isopropyl-4-(2,1,3-benzoxadiazool-4-yl)-2,6-dimethyl-1,4-dihydro pyridine-3,5-dicarboxylaat en farmaceutisch preparaat dat deze verbinding bevat. | |
CS228506B2 (en) | Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid | |
CH633266A5 (en) | Process for preparing 1,4-dihydropyridine compounds | |
SE446265B (sv) | 2-metyl-1,4-dihydropyridinforeningar | |
US4808718A (en) | Fused polycyclic and bridged compounds useful as calcium channel blockers | |
CA2078606A1 (en) | Dihydropyridine derivatives useful in antitumor therapy | |
US4753936A (en) | Circulation-active substituted 1,4-dihydropyridine-3-carboxylic acid piperazides | |
US4069322A (en) | Pro-drugs for the improved delivery of certain selected anti-inflammatory steroids | |
Taylor et al. | 2-(2-Aryl-2-oxoethylidene)-1, 2, 3, 4-tetrahydropyridines. Novel isomers of 1, 4-dihydropyridine calcium channel blockers | |
EP0220653B1 (en) | 3-aminocarbonyl-1,4-dihydropyridine-5-carboxylic acid compounds, process for preparation and use thereof, and pharmaceutical composition containing the same | |
JP2005505621A5 (ja) | ||
JPH01319479A (ja) | 5―アミノメチル―2―フラノメタノールの新規な誘導体、その製造及び使用 | |
US4562203A (en) | Rifamycins derivatives and preparation and pharmaceutical compositions thereof | |
US4180581A (en) | N-9,10-dihydrolysergyl-m-aminobenzoic acid amide derivative | |
EP0093945A2 (en) | 1,4-Dihydropyridine derivatives | |
EP0160451B1 (en) | Dihydropyridine-3,5-dicarboxylic acid ester derivative isomers, their preparation, and pharmaceutical compositions containing them | |
US4659707A (en) | Aminoacyl derivatives of 4,9-dihydro-10H-pyrido[3,2-b]thieno[3,2-e][1,4]diazepinone and of 4,9-dihydro-10H-pyrido[3,2-b]thieno[3,4-e][1,4]diazepinone, their preparation and pharmaceutical compositions containing them | |
US4138482A (en) | 3-Cyano-N-(N,N-dimethylaminopropyl)-iminodibenzyl and salts thereof | |
US4567271A (en) | Benzoxadiazoles and benzothiadiazoles | |
US4491581A (en) | 4-(2,1,3-Benzoxadiazol-4-yl)-1,4-dihydropyridazine derivatives, their production and pharmaceutical compositions | |
JPH0155268B2 (ja) | ||
HU193786B (en) | Process for producing dihydropyridine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired | ||
ND | Supplementary protection certificate (spc) granted | ||
SPCG | Supplementary protection certificate granted |
Spc suppl protection certif: L45 Extension date: 20030612 |
|
PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
MA | Patent expired |
Owner name: NOVARTIS AG |